Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.

Tan HZ, Wu ZY, Wu JY, Long L, Jiao JW, Peng YH, Xu YW, Li SS, Wang W, Zhang JJ, Li EM, Xu LY.

BMC Cancer. 2016 Jul 29;16:560. doi: 10.1186/s12885-016-2588-3.

2.

The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population.

Peng H, Wang LG, Wang XZ, Liu AJ.

Pathol Res Pract. 2017 Dec;213(12):1482-1488. doi: 10.1016/j.prp.2017.10.008. Epub 2017 Oct 9.

PMID:
29037837
3.

Decreased risk of developing cancer in subjects carrying SLC52A3 rs13042395 polymorphism: proof from a meta-analysis.

Li J, Wang S, Li M, Xu H, Li D, Yin C, Zhao J, Li F.

Biomark Med. 2016 Oct;10(10):1105-1118. Epub 2016 Sep 7. Review.

PMID:
27600099
4.

Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma.

Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B.

PLoS One. 2013 Dec 4;8(12):e81999. doi: 10.1371/journal.pone.0081999. eCollection 2013.

5.

Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.

Motoyama S, Mori K, Kamei T, Miura M, Hinai Y, Sato Y, Yoshino K, Sasaki T, Miyata G, Seto Y, Ogawa J.

Ann Surg Oncol. 2013 Jun;20(6):1978-84. doi: 10.1245/s10434-012-2765-9. Epub 2012 Dec 5.

PMID:
23212764
6.

Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population.

Piao JM, Shin MH, Kim HN, Song HR, Kweon SS, Choi JS, Shim HJ, Hwang JE, Bae WK, Kim SH, Choi YD, Cui LH.

Dis Esophagus. 2014 Nov-Dec;27(8):798-801. doi: 10.1111/dote.12155. Epub 2013 Oct 24.

PMID:
24152165
7.

A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population.

Wu F, Li M, You W, Ji Y, Cui X, Hu J, Chen Y, Pang L, Li S, Wei Y, Yang L, Li F.

Genet Test Mol Biomarkers. 2018 Jan;22(1):29-34. doi: 10.1089/gtmb.2017.0115. Epub 2017 Dec 11.

PMID:
29227754
8.

Functional SNPs in human C20orf54 gene influence susceptibility to esophageal squamous cell carcinoma.

Ji A, Wang J, Yang J, Wei Z, Lian C, Ma L, Ma L, Chen J, Qin X, Wang Ld, Wei W.

Asian Pac J Cancer Prev. 2011;12(12):3207-12.

9.

Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.

Wang YL, Bai Y, Yao WJ, Guo L, Wang ZM.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11871-6. eCollection 2015.

10.
11.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
12.

[Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].

Zhang XF, Wang YM, Wang R, Wei LZ, Li Y, Guo W, Wang N, Zhang JH.

Ai Zheng. 2005 May;24(5):513-9. Chinese.

PMID:
15890089
13.

Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers.

Zhou RM, Li Y, Liu JH, Wang N, Huang X, Cao SR, Shan BE.

Cancer Biomark. 2017 Dec 12;21(1):65-71. doi: 10.3233/CBM-170269.

PMID:
29060926
14.

Esophageal Squamous Cell Carcinoma and Gastric Cardia Adenocarcinoma Shared Susceptibility Locus in C20orf54: Evidence from Published Studies.

Duan F, Cui S, Song C, Zhao X, Dai L, Shen Y.

Sci Rep. 2015 Jul 8;5:11961. doi: 10.1038/srep11961. Review.

15.

The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.

Han T, Wang Z, Yang Y, Shu T, Li W, Liu D, Li P, Qi R, Ren Y, Li L, Liu H, Zhang S, Zhang L.

Oncol Rep. 2015 Sep;34(3):1353-60. doi: 10.3892/or.2015.4090. Epub 2015 Jun 26.

PMID:
26135942
16.

SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.

Long L, Pang XX, Lei F, Zhang JS, Wang W, Liao LD, Xu XE, He JZ, Wu JY, Wu ZY, Wang LD, Lin DC, Li EM, Xu LY.

Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.

17.

Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.

Sun ZG, Wang Z.

Dis Esophagus. 2011 Apr;24(3):182-8. doi: 10.1111/j.1442-2050.2010.01125.x. Epub 2010 Nov 12.

PMID:
21073618
18.

Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population.

Cui XB, Chen YZ, Pang XL, Liu W, Hu JM, Li SG, Yang L, Zhang WJ, Liu CX, Cao YW, Jiang JF, Gu WY, Pang J, Yang L, Yuan XL, Yu SY, Li F.

Gene. 2013 Nov 10;530(2):315-22. doi: 10.1016/j.gene.2013.08.057. Epub 2013 Aug 24.

PMID:
23981775
19.

Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.

Yang PW, Hsieh MS, Huang YC, Hsieh CY, Chiang TH, Lee JM.

PLoS One. 2014 Jun 19;9(6):e100326. doi: 10.1371/journal.pone.0100326. eCollection 2014.

20.

Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.

Hsu PK, Kao HL, Chen HY, Yen CC, Wu YC, Hsu WH, Chou TY.

J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.

Supplemental Content

Support Center